Marex Group »

Kala Pharmaceuticals shares owned by Marex Group

Quarter-by-quarter ownership of Kala Pharmaceuticals (KALA) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Kala Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kala Pharmaceuticals held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kala Pharmaceuticals by Marex Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $35k 15k 2.42

More positions owned by Marex Group

Tesla Motors Call Option (TSLA)
Mastercard Incorporated Cl A (MA)
Booking Holdings (BKNG)
Microsoft Corporation Call Option (MSFT)
Strategy Cl A New (MSTR)
UnitedHealth (UNH)
NVIDIA Corporation Call Option (NVDA)
Eli Lilly & Co. (LLY)
Valkyrie Bitcoin (BRRR)
Apple (AAPL)
Netflix (NFLX)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Meta Platforms Cl A (META)
Broadcom Call Option (AVGO)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)

View all positions for Marex Group

Top funds holding Kala Pharmaceuticals

Baker Bros. Advisors
Woodline Partners
Vanguard Group
ADAR1 Capital Management
Geode Capital Management
State Street Corporation
BlackRock
Marex Group
Northern Trust
UBS Group
Tower Research Capital
Covestor
Morgan Stanley
Caitong International Asset Management
MAI Wealth Advisors

View all funds holding Kala Pharmaceuticals